Protease Activated Receptors: A Pathway to Boosting Mesenchymal Stromal Cell Therapeutic Efficacy in Acute Respiratory Distress Syndrome?

Acute Respiratory Distress Syndrome is the most common cause of respiratory failure among critically ill patients, and its importance has been heightened during the COVID-19 pandemic. Even with the best supportive care, the mortality rate in the most severe cases is 40–50%, and the only pharmacologi...

Descripción completa

Detalles Bibliográficos
Autor principal: Gupta, Naveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836081/
https://www.ncbi.nlm.nih.gov/pubmed/35163205
http://dx.doi.org/10.3390/ijms23031277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836081/
https://www.ncbi.nlm.nih.gov/pubmed/35163205
http://dx.doi.org/10.3390/ijms23031277

Ejemplares similares